Skip to main content
. 2017 Jan 12;2017:7350251. doi: 10.1155/2017/7350251

Figure 6.

Figure 6

Effects of SXD on intestinal proliferating cells and ISCs of rats after irinotecan administration (×100). ((a) and (f)) Blank control group; ((b) and (g)) model control group; ((c) and (h)) low-dose SXD group; ((d) and (i)) middle-dose SXD group; ((e) and (j)) high-dose SXD group.